231 related articles for article (PubMed ID: 15152076)
1. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes.
Pittman J; Huang E; Dressman H; Horng CF; Cheng SH; Tsou MH; Chen CM; Bild A; Iversen ES; Huang AT; Nevins JR; West M
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8431-6. PubMed ID: 15152076
[TBL] [Abstract][Full Text] [Related]
2. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction.
Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R153-7. PubMed ID: 12928487
[TBL] [Abstract][Full Text] [Related]
3. Gene expression predictors of breast cancer outcomes.
Huang E; Cheng SH; Dressman H; Pittman J; Tsou MH; Horng CF; Bild A; Iversen ES; Liao M; Chen CM; West M; Nevins JR; Huang AT
Lancet; 2003 May; 361(9369):1590-6. PubMed ID: 12747878
[TBL] [Abstract][Full Text] [Related]
4. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.
Shen R; Ghosh D; Chinnaiyan AM
BMC Genomics; 2004 Dec; 5(1):94. PubMed ID: 15598354
[TBL] [Abstract][Full Text] [Related]
5. Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.
Zhang X; Li Y; Akinyemiju T; Ojesina AI; Buckhaults P; Liu N; Xu B; Yi N
Genetics; 2017 Jan; 205(1):89-100. PubMed ID: 28049703
[TBL] [Abstract][Full Text] [Related]
6. Bayesian analysis of binary prediction tree models for retrospectively sampled outcomes.
Pittman J; Huang E; Nevins J; Wang Q; West M
Biostatistics; 2004 Oct; 5(4):587-601. PubMed ID: 15475421
[TBL] [Abstract][Full Text] [Related]
7. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.
Huang Y; Ma SF; Vij R; Oldham JM; Herazo-Maya J; Broderick SM; Strek ME; White SR; Hogarth DK; Sandbo NK; Lussier YA; Gibson KF; Kaminski N; Garcia JG; Noth I
BMC Pulm Med; 2015 Nov; 15():147. PubMed ID: 26589497
[TBL] [Abstract][Full Text] [Related]
8. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
9. Genomic medicine. Gene expression tests foretell breast cancer's future.
Garber K
Science; 2004 Mar; 303(5665):1754-5. PubMed ID: 15031473
[No Abstract] [Full Text] [Related]
10. Combining gene signatures improves prediction of breast cancer survival.
Zhao X; Rødland EA; Sørlie T; Naume B; Langerød A; Frigessi A; Kristensen VN; Børresen-Dale AL; Lingjærde OC
PLoS One; 2011 Mar; 6(3):e17845. PubMed ID: 21423775
[TBL] [Abstract][Full Text] [Related]
11. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
Miller LD; Liu ET
Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
[TBL] [Abstract][Full Text] [Related]
12. Increased Proportion of Variance Explained and Prediction Accuracy of Survival of Breast Cancer Patients with Use of Whole-Genome Multiomic Profiles.
Vazquez AI; Veturi Y; Behring M; Shrestha S; Kirst M; Resende MF; de Los Campos G
Genetics; 2016 Jul; 203(3):1425-38. PubMed ID: 27129736
[TBL] [Abstract][Full Text] [Related]
13. A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer.
Huang S; Yee C; Ching T; Yu H; Garmire LX
PLoS Comput Biol; 2014 Sep; 10(9):e1003851. PubMed ID: 25233347
[TBL] [Abstract][Full Text] [Related]
14. Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information.
Li L
Bioinformatics; 2006 Feb; 22(4):466-71. PubMed ID: 16339281
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer prognostic biomarker using attractor metagenes and the FGD3-SUSD3 metagene.
Ou Yang TH; Cheng WY; Zheng T; Maurer MA; Anastassiou D
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2850-6. PubMed ID: 25249324
[TBL] [Abstract][Full Text] [Related]
16. Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial.
Sonnenblick A; Brohée S; Fumagalli D; Rothé F; Vincent D; Ignatiadis M; Desmedt C; Salgado R; Sirtaine N; Loi S; Neven P; Loibl S; Denkert C; Joensuu H; Piccart M; Sotiriou C
Oncotarget; 2015 Oct; 6(30):30306-16. PubMed ID: 26358523
[TBL] [Abstract][Full Text] [Related]
17. Embracing the complexity of genomic data for personalized medicine.
West M; Ginsburg GS; Huang AT; Nevins JR
Genome Res; 2006 May; 16(5):559-66. PubMed ID: 16651662
[TBL] [Abstract][Full Text] [Related]
18. Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.
Callari M; Musella V; Di Buduo E; Sensi M; Miodini P; Dugo M; Orlandi R; Agresti R; Paolini B; Carcangiu ML; Cappelletti V; Daidone MG
Mol Oncol; 2014 Oct; 8(7):1278-89. PubMed ID: 24853384
[TBL] [Abstract][Full Text] [Related]
19. Predicting features of breast cancer with gene expression patterns.
Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
[TBL] [Abstract][Full Text] [Related]
20. Genomic prediction of locoregional recurrence after mastectomy in breast cancer.
Cheng SH; Horng CF; West M; Huang E; Pittman J; Tsou MH; Dressman H; Chen CM; Tsai SY; Jian JJ; Liu MC; Nevins JR; Huang AT
J Clin Oncol; 2006 Oct; 24(28):4594-602. PubMed ID: 17008701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
